ID   S23A2_HUMAN             Reviewed;         650 AA.
AC   Q9UGH3; B4DJZ1; Q8WWR4; Q92512; Q96D54; Q9UNU1; Q9UP85;
DT   19-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   28-JUN-2023, entry version 190.
DE   RecName: Full=Solute carrier family 23 member 2;
DE   AltName: Full=Na(+)/L-ascorbic acid transporter 2;
DE   AltName: Full=Nucleobase transporter-like 1 protein {ECO:0000303|PubMed:9804989};
DE   AltName: Full=Sodium-dependent vitamin C transporter 2 {ECO:0000303|PubMed:10471399};
DE            Short=hSVCT2 {ECO:0000303|PubMed:10471399};
DE   AltName: Full=Yolk sac permease-like molecule 2 {ECO:0000303|PubMed:9804989};
GN   Name=SLC23A2;
GN   Synonyms=KIAA0238 {ECO:0000303|PubMed:9039502}, NBTL1, SLC23A1, SVCT2
GN   {ECO:0000303|PubMed:10471399}, YSPL2 {ECO:0000303|PubMed:9804989};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=9804989; DOI=10.1016/s0167-4781(98)00151-1;
RA   Faaland C.A., Race J.E., Ricken G., Warner F.J., Williams W.J.,
RA   Holtzman E.J.;
RT   "Molecular characterization of two novel transporters from human and mouse
RT   kidney and from LLC-PK1 cells reveals a novel conserved family that is
RT   homologous to bacterial and Aspergillus nucleobase transporters.";
RL   Biochim. Biophys. Acta 1442:353-360(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TRANSPORTER ACTIVITY, AND
RP   TISSUE SPECIFICITY.
RC   TISSUE=Choriocarcinoma;
RX   PubMed=10471399; DOI=10.1006/bbrc.1999.1272;
RA   Rajan D.P., Huang W., Dutta B., Devoe L.D., Leibach F.H., Ganapathy V.,
RA   Prasad P.D.;
RT   "Human placental sodium-dependent vitamin C transporter (SVCT2): molecular
RT   cloning and transport function.";
RL   Biochem. Biophys. Res. Commun. 262:762-768(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND PHOSPHORYLATION.
RC   TISSUE=Kidney;
RX   PubMed=10556521; DOI=10.1016/s0014-5793(99)01393-9;
RA   Daruwala R.C., Song J., Koh W.S., Rumsey S.C., Levine M.;
RT   "Cloning and functional characterization of the human sodium-dependent
RT   vitamin C transporters hSVCT1 and hSVCT2.";
RL   FEBS Lett. 460:480-484(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Mammary carcinoma;
RX   PubMed=10395795; DOI=10.1006/geno.1999.5847;
RA   Hogue D.L., Ling V.;
RT   "A human nucleobase transporter-like cDNA (SLC23A1): member of a
RT   transporter family conserved from bacteria to mammals.";
RL   Genomics 59:18-23(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=11396616; DOI=10.1080/09687680110033774;
RA   Liang W.J., Johnson D., Jarvis S.M.;
RT   "Vitamin C transport systems of mammalian cells.";
RL   Mol. Membr. Biol. 18:87-95(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Trachea;
RA   Schwarzer C., Borcanski G., Widdicombe J., Fischer H., Illek B.;
RT   "SVCT2 in ciliated human tracheal epithelial cultures.";
RL   Submitted (SEP-2003) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9039502; DOI=10.1093/dnares/3.5.321;
RA   Nagase T., Seki N., Ishikawa K., Ohira M., Kawarabayasi Y., Ohara O.,
RA   Tanaka A., Kotani H., Miyajima N., Nomura N.;
RT   "Prediction of the coding sequences of unidentified human genes. VI. The
RT   coding sequences of 80 new genes (KIAA0201-KIAA0280) deduced by analysis of
RT   cDNA clones from cell line KG-1 and brain.";
RL   DNA Res. 3:321-329(1996).
RN   [8]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Thalamus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11780052; DOI=10.1038/414865a;
RA   Deloukas P., Matthews L.H., Ashurst J.L., Burton J., Gilbert J.G.R.,
RA   Jones M., Stavrides G., Almeida J.P., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Barlow K.F., Bates K.N., Beard L.M., Beare D.M., Beasley O.P.,
RA   Bird C.P., Blakey S.E., Bridgeman A.M., Brown A.J., Buck D., Burrill W.D.,
RA   Butler A.P., Carder C., Carter N.P., Chapman J.C., Clamp M., Clark G.,
RA   Clark L.N., Clark S.Y., Clee C.M., Clegg S., Cobley V.E., Collier R.E.,
RA   Connor R.E., Corby N.R., Coulson A., Coville G.J., Deadman R., Dhami P.D.,
RA   Dunn M., Ellington A.G., Frankland J.A., Fraser A., French L., Garner P.,
RA   Grafham D.V., Griffiths C., Griffiths M.N.D., Gwilliam R., Hall R.E.,
RA   Hammond S., Harley J.L., Heath P.D., Ho S., Holden J.L., Howden P.J.,
RA   Huckle E., Hunt A.R., Hunt S.E., Jekosch K., Johnson C.M., Johnson D.,
RA   Kay M.P., Kimberley A.M., King A., Knights A., Laird G.K., Lawlor S.,
RA   Lehvaeslaiho M.H., Leversha M.A., Lloyd C., Lloyd D.M., Lovell J.D.,
RA   Marsh V.L., Martin S.L., McConnachie L.J., McLay K., McMurray A.A.,
RA   Milne S.A., Mistry D., Moore M.J.F., Mullikin J.C., Nickerson T.,
RA   Oliver K., Parker A., Patel R., Pearce T.A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Prathalingam S.R., Plumb R.W., Ramsay H., Rice C.M.,
RA   Ross M.T., Scott C.E., Sehra H.K., Shownkeen R., Sims S., Skuce C.D.,
RA   Smith M.L., Soderlund C., Steward C.A., Sulston J.E., Swann R.M.,
RA   Sycamore N., Taylor R., Tee L., Thomas D.W., Thorpe A., Tracey A.,
RA   Tromans A.C., Vaudin M., Wall M., Wallis J.M., Whitehead S.L.,
RA   Whittaker P., Willey D.L., Williams L., Williams S.A., Wilming L.,
RA   Wray P.W., Hubbard T., Durbin R.M., Bentley D.R., Beck S., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 20.";
RL   Nature 414:865-871(2001).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-424 (ISOFORM 1).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   SUBCELLULAR LOCATION, AND TOPOLOGY.
RX   PubMed=19379732; DOI=10.1016/j.yexcr.2009.04.007;
RA   Velho A.M., Jarvis S.M.;
RT   "Topological studies of hSVCT1, the human sodium-dependent vitamin C
RT   transporter and the influence of N-glycosylation on its intracellular
RT   targeting.";
RL   Exp. Cell Res. 315:2312-2321(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-81, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-81, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   INTERACTION WITH CLSTN3.
RX   PubMed=34673103; DOI=10.1016/j.ijbiomac.2021.10.058;
RA   Subramanian V.S., Teafatiller T., Vidal J., Gunaratne G.S.,
RA   Rodriguez-Ortiz C.J., Kitazawa M., Marchant J.S.;
RT   "Calsyntenin-3 interacts with the sodium-dependent vitamin C transporter-2
RT   to regulate vitamin C uptake.";
RL   Int. J. Biol. Macromol. 192:1178-1184(2021).
CC   -!- FUNCTION: Sodium/ascorbate cotransporter (PubMed:10471399,
CC       PubMed:10556521). Mediates electrogenic uptake of vitamin C, with a
CC       stoichiometry of 2 Na(+) for each ascorbate (PubMed:10471399).
CC       {ECO:0000269|PubMed:10471399, ECO:0000269|PubMed:10556521}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-ascorbate(out) + 2 Na(+)(out) = L-ascorbate(in) + 2
CC         Na(+)(in); Xref=Rhea:RHEA:69883, ChEBI:CHEBI:29101,
CC         ChEBI:CHEBI:38290; Evidence={ECO:0000269|PubMed:10471399};
CC   -!- SUBUNIT: Interacts with CLSTN3. {ECO:0000269|PubMed:34673103}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:19379732};
CC       Multi-pass membrane protein {ECO:0000269|PubMed:19379732}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UGH3-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UGH3-2; Sequence=VSP_056485;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. {ECO:0000269|PubMed:10471399}.
CC   -!- PTM: Phosphorylated. {ECO:0000269|PubMed:10556521}.
CC   -!- SIMILARITY: Belongs to the nucleobase:cation symporter-2 (NCS2)
CC       (TC 2.A.40) family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA13244.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF058319; AAC78806.1; -; mRNA.
DR   EMBL; AJ269478; CAB58120.1; -; mRNA.
DR   EMBL; AF164142; AAF80493.1; -; mRNA.
DR   EMBL; AF092511; AAD11783.1; -; mRNA.
DR   EMBL; AJ292318; CAC83100.1; -; mRNA.
DR   EMBL; AY380556; AAQ79775.1; -; mRNA.
DR   EMBL; D87075; BAA13244.2; ALT_INIT; mRNA.
DR   EMBL; AK296304; BAG59003.1; -; mRNA.
DR   EMBL; AL109841; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL121890; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL389886; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC013112; AAH13112.1; -; mRNA.
DR   CCDS; CCDS13085.1; -. [Q9UGH3-1]
DR   PIR; JC7095; JC7095.
DR   RefSeq; NP_005107.4; NM_005116.5. [Q9UGH3-1]
DR   RefSeq; NP_976072.1; NM_203327.1. [Q9UGH3-1]
DR   RefSeq; XP_011527716.1; XM_011529414.2.
DR   RefSeq; XP_011527717.1; XM_011529415.2.
DR   RefSeq; XP_011527718.1; XM_011529416.2.
DR   RefSeq; XP_011527719.1; XM_011529417.2.
DR   RefSeq; XP_016883660.1; XM_017028171.1.
DR   RefSeq; XP_016883661.1; XM_017028172.1.
DR   RefSeq; XP_016883662.1; XM_017028173.1.
DR   RefSeq; XP_016883663.1; XM_017028174.1.
DR   RefSeq; XP_016883665.1; XM_017028176.1.
DR   RefSeq; XP_016883666.1; XM_017028177.1.
DR   AlphaFoldDB; Q9UGH3; -.
DR   PCDDB; Q9UGH3; -.
DR   SMR; Q9UGH3; -.
DR   BioGRID; 115287; 26.
DR   IntAct; Q9UGH3; 11.
DR   MINT; Q9UGH3; -.
DR   STRING; 9606.ENSP00000368637; -.
DR   ChEMBL; CHEMBL3271; -.
DR   DrugBank; DB00126; Ascorbic acid.
DR   DrugCentral; Q9UGH3; -.
DR   TCDB; 2.A.40.6.2; the nucleobase/ascorbate transporter (nat) or nucleobase:cation symporter-2 (ncs2) family.
DR   GlyCosmos; Q9UGH3; 2 sites, No reported glycans.
DR   GlyGen; Q9UGH3; 3 sites, 1 O-linked glycan (1 site).
DR   iPTMnet; Q9UGH3; -.
DR   PhosphoSitePlus; Q9UGH3; -.
DR   SwissPalm; Q9UGH3; -.
DR   BioMuta; SLC23A2; -.
DR   DMDM; 24212469; -.
DR   EPD; Q9UGH3; -.
DR   jPOST; Q9UGH3; -.
DR   MassIVE; Q9UGH3; -.
DR   MaxQB; Q9UGH3; -.
DR   PaxDb; Q9UGH3; -.
DR   PeptideAtlas; Q9UGH3; -.
DR   ProteomicsDB; 4421; -.
DR   ProteomicsDB; 84214; -. [Q9UGH3-1]
DR   Antibodypedia; 42663; 136 antibodies from 23 providers.
DR   DNASU; 9962; -.
DR   Ensembl; ENST00000338244.6; ENSP00000344322.1; ENSG00000089057.15. [Q9UGH3-1]
DR   Ensembl; ENST00000379333.5; ENSP00000368637.1; ENSG00000089057.15. [Q9UGH3-1]
DR   GeneID; 9962; -.
DR   KEGG; hsa:9962; -.
DR   MANE-Select; ENST00000338244.6; ENSP00000344322.1; NM_005116.6; NP_005107.4.
DR   UCSC; uc002wlg.1; human. [Q9UGH3-1]
DR   AGR; HGNC:10973; -.
DR   CTD; 9962; -.
DR   DisGeNET; 9962; -.
DR   GeneCards; SLC23A2; -.
DR   HGNC; HGNC:10973; SLC23A2.
DR   HPA; ENSG00000089057; Tissue enhanced (adrenal gland, choroid plexus, retina).
DR   MIM; 603791; gene.
DR   neXtProt; NX_Q9UGH3; -.
DR   OpenTargets; ENSG00000089057; -.
DR   PharmGKB; PA35849; -.
DR   VEuPathDB; HostDB:ENSG00000089057; -.
DR   eggNOG; KOG1292; Eukaryota.
DR   GeneTree; ENSGT00950000182953; -.
DR   HOGENOM; CLU_017959_5_4_1; -.
DR   InParanoid; Q9UGH3; -.
DR   OMA; NNVSAYC; -.
DR   OrthoDB; 911690at2759; -.
DR   PhylomeDB; Q9UGH3; -.
DR   TreeFam; TF313272; -.
DR   PathwayCommons; Q9UGH3; -.
DR   Reactome; R-HSA-196836; Vitamin C (ascorbate) metabolism.
DR   SignaLink; Q9UGH3; -.
DR   BioGRID-ORCS; 9962; 10 hits in 1165 CRISPR screens.
DR   ChiTaRS; SLC23A2; human.
DR   GeneWiki; SLC23A2; -.
DR   GenomeRNAi; 9962; -.
DR   Pharos; Q9UGH3; Tbio.
DR   PRO; PR:Q9UGH3; -.
DR   Proteomes; UP000005640; Chromosome 20.
DR   RNAct; Q9UGH3; protein.
DR   Bgee; ENSG00000089057; Expressed in adrenal tissue and 180 other tissues.
DR   ExpressionAtlas; Q9UGH3; baseline and differential.
DR   Genevisible; Q9UGH3; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0016323; C:basolateral plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0016020; C:membrane; IC:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0008520; F:L-ascorbate:sodium symporter activity; IDA:UniProtKB.
DR   GO; GO:0015229; F:L-ascorbic acid transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0071361; P:cellular response to ethanol; IEA:Ensembl.
DR   GO; GO:0019852; P:L-ascorbic acid metabolic process; IBA:GO_Central.
DR   GO; GO:0015882; P:L-ascorbic acid transmembrane transport; IDA:UniProtKB.
DR   GO; GO:1901215; P:negative regulation of neuron death; IEA:Ensembl.
DR   GO; GO:1903861; P:positive regulation of dendrite extension; IEA:Ensembl.
DR   GO; GO:0006979; P:response to oxidative stress; IEA:Ensembl.
DR   InterPro; IPR006043; NCS2.
DR   InterPro; IPR006042; Xan_ur_permease.
DR   PANTHER; PTHR11119:SF33; SOLUTE CARRIER FAMILY 23 MEMBER 2; 1.
DR   PANTHER; PTHR11119; XANTHINE-URACIL / VITAMIN C PERMEASE FAMILY MEMBER; 1.
DR   Pfam; PF00860; Xan_ur_permease; 1.
DR   PROSITE; PS01116; XANTH_URACIL_PERMASE; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Cell adhesion; Cell membrane; Glycoprotein;
KW   Ion transport; Membrane; Phosphoprotein; Reference proteome; Repeat;
KW   Sodium; Sodium transport; Symport; Transmembrane; Transmembrane helix;
KW   Transport.
FT   CHAIN           1..650
FT                   /note="Solute carrier family 23 member 2"
FT                   /id="PRO_0000165978"
FT   TOPO_DOM        9..110
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        111..131
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        132..139
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        140..160
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        161
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        162..182
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        183..218
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        219..239
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        240..266
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        267..284
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        285..288
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   INTRAMEM        289..302
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        303..309
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        310..330
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        331..371
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        372..392
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        393..417
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        418..438
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        439..461
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        462..482
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        483..485
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        486..506
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        507..516
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        517..537
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        538..547
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        548..568
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        569..650
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   REGION          1..21
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..17
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         70
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9EPR4"
FT   MOD_RES         75
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9WTW8"
FT   MOD_RES         78
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9EPR4"
FT   MOD_RES         79
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9EPR4"
FT   MOD_RES         81
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:19690332,
FT                   ECO:0007744|PubMed:23186163"
FT   MOD_RES         649
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9EPR4"
FT   CARBOHYD        188
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        196
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         162..275
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056485"
FT   CONFLICT        30
FT                   /note="P -> R (in Ref. 4; AAD11783)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        141
FT                   /note="I -> T (in Ref. 4; AAD11783)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        167
FT                   /note="A -> T (in Ref. 1; AAC78806)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        182
FT                   /note="L -> S (in Ref. 4; AAD11783)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        215
FT                   /note="I -> V (in Ref. 4; AAD11783)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        314
FT                   /note="F -> L (in Ref. 5; CAC83100)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        418..424
FT                   /note="GIFVEGL -> YVPEKTS (in Ref. 11)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   650 AA;  70337 MW;  28C9E190D9528D39 CRC64;
     MMGIGKNTTS KSMEAGSSTE GKYEDEAKHP AFFTLPVVIN GGATSSGEQD NEDTELMAIY
     TTENGIAEKS SLAETLDSTG SLDPQRSDMI YTIEDVPPWY LCIFLGLQHY LTCFSGTIAV
     PFLLADAMCV GYDQWATSQL IGTIFFCVGI TTLLQTTFGC RLPLFQASAF AFLAPARAIL
     SLDKWKCNTT DVSVANGTAE LLHTEHIWYP RIREIQGAII MSSLIEVVIG LLGLPGALLK
     YIGPLTITPT VALIGLSGFQ AAGERAGKHW GIAMLTIFLV LLFSQYARNV KFPLPIYKSK
     KGWTAYKLQL FKMFPIILAI LVSWLLCFIF TVTDVFPPDS TKYGFYARTD ARQGVLLVAP
     WFKVPYPFQW GLPTVSAAGV IGMLSAVVAS IIESIGDYYA CARLSCAPPP PIHAINRGIF
     VEGLSCVLDG IFGTGNGSTS SSPNIGVLGI TKVGSRRVIQ CGAALMLALG MIGKFSALFA
     SLPDPVLGAL FCTLFGMITA VGLSNLQFID LNSSRNLFVL GFSIFFGLVL PSYLRQNPLV
     TGITGIDQVL NVLLTTAMFV GGCVAFILDN TIPGTPEERG IRKWKKGVGK GNKSLDGMES
     YNLPFGMNII KKYRCFSYLP ISPTFVGYTW KGLRKSDNSR SSDEDSQATG
//
